Sarah James
Stock Analyst at Cantor Fitzgerald
(4.10)
# 1,647
Out of 4,988 analysts
500
Total ratings
55.7%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiated Coverage: Buy | $80 | $77.84 | +2.77% | 1 | Sep 2, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $13 → $5 | $3.04 | +64.47% | 2 | Aug 17, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $21 | $14.28 | +47.06% | 2 | Aug 17, 2026 | |
| SGRY Surgery Partners | Reiterated: Buy | $33 → $18 | $13.25 | +35.85% | 10 | Aug 10, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $27.13 | +14.26% | 14 | Aug 6, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $15 | $3.22 | +365.84% | 12 | Aug 5, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Hold | $30 | $28.33 | +5.89% | 17 | Jul 29, 2026 | |
| TDOC Teladoc Health | Reiterated: Buy | $10 | $6.30 | +58.73% | 8 | Jul 29, 2026 | |
| CNC Centene | Reiterated: Buy | $75 | $65.11 | +15.19% | 58 | Jul 28, 2026 | |
| UHS Universal Health Services | Reiterated: Hold | $194 | $176.69 | +9.80% | 37 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $209 | $200.79 | +4.09% | 42 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 | $261.99 | -6.48% | 29 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $427.71 | +22.75% | 35 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $110 | $88.84 | +23.82% | 23 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $450 | $410.95 | +9.50% | 29 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $201 → $300 | $386.22 | -22.32% | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.3592 | +735.19% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.79 | +67.60% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $340 | $275.28 | +23.51% | 28 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.7341 | +853.55% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.77 | +67.71% | 1 | Feb 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 | $376.90 | +16.74% | 45 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $28 | $27.29 | n/a | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $10.92 | n/a | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $5 | $13.67 | n/a | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128 → $103 | $183.86 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $57 | $34.36 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $56 → $76 | $121.75 | n/a | 13 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $0.4672 | n/a | 1 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $80 | $84.84 | n/a | 7 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $2.87 | n/a | 12 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $290 | $393.33 | n/a | 1 | Oct 19, 2017 |
Tempus AI
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $77.84
Upside: +2.77%
CVRx, Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $13 → $5
Current: $3.04
Upside: +64.47%
NeuroPace
Aug 17, 2026
Reiterated: Buy
Price Target: $21
Current: $14.28
Upside: +47.06%
Surgery Partners
Aug 10, 2026
Reiterated: Buy
Price Target: $33 → $18
Current: $13.25
Upside: +35.85%
Progyny
Aug 6, 2026
Reiterated: Buy
Price Target: $31
Current: $27.13
Upside: +14.26%
LifeMD
Aug 5, 2026
Reiterated: Buy
Price Target: $15
Current: $3.22
Upside: +365.84%
Acadia Healthcare Company
Jul 29, 2026
Reiterated: Hold
Price Target: $30
Current: $28.33
Upside: +5.89%
Teladoc Health
Jul 29, 2026
Reiterated: Buy
Price Target: $10
Current: $6.30
Upside: +58.73%
Centene
Jul 28, 2026
Reiterated: Buy
Price Target: $75
Current: $65.11
Upside: +15.19%
Universal Health Services
Jul 28, 2026
Reiterated: Hold
Price Target: $194
Current: $176.69
Upside: +9.80%
Jul 23, 2026
Reiterated: Hold
Price Target: $209
Current: $200.79
Upside: +4.09%
Jul 23, 2026
Reiterated: Buy
Price Target: $245
Current: $261.99
Upside: -6.48%
Jul 14, 2026
Reiterated: Buy
Price Target: $525
Current: $427.71
Upside: +22.75%
Jul 7, 2026
Reiterated: Buy
Price Target: $95 → $110
Current: $88.84
Upside: +23.82%
Jul 7, 2026
Reiterated: Buy
Price Target: $400 → $450
Current: $410.95
Upside: +9.50%
Jul 7, 2026
Reiterated: Hold
Price Target: $201 → $300
Current: $386.22
Upside: -22.32%
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $0.3592
Upside: +735.19%
May 8, 2026
Reiterated: Hold
Price Target: $3
Current: $1.79
Upside: +67.60%
Apr 30, 2026
Reiterated: Buy
Price Target: $365 → $340
Current: $275.28
Upside: +23.51%
Apr 20, 2026
Reiterated: Buy
Price Target: $7
Current: $0.7341
Upside: +853.55%
Feb 15, 2026
Reiterated: Buy
Price Target: $8
Current: $4.77
Upside: +67.71%
Jan 28, 2026
Reiterated: Buy
Price Target: $440
Current: $376.90
Upside: +16.74%
Jun 13, 2025
Reiterated: Buy
Price Target: $33 → $28
Current: $27.29
Upside: n/a
Sep 15, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $10.92
Upside: n/a
Aug 19, 2022
Reiterated: Buy
Price Target: $7 → $5
Current: $13.67
Upside: n/a
Aug 16, 2022
Reiterated: Hold
Price Target: $128 → $103
Current: $183.86
Upside: n/a
Aug 5, 2022
Reiterated: Hold
Price Target: $50 → $57
Current: $34.36
Upside: n/a
Nov 23, 2020
Upgraded: Buy
Price Target: $56 → $76
Current: $121.75
Upside: n/a
Jun 15, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $0.4672
Upside: n/a
Nov 11, 2019
Reiterated: Buy
Price Target: $96 → $80
Current: $84.84
Upside: n/a
Aug 7, 2019
Reiterated: Sell
Price Target: $4 → $3
Current: $2.87
Upside: n/a
Oct 19, 2017
Reiterated: Hold
Price Target: $290
Current: $393.33
Upside: n/a